|Bid||139.48 x 800|
|Ask||332.52 x 800|
|Day's range||212.50 - 216.54|
|52-week range||189.40 - 253.67|
|Beta (5Y monthly)||0.47|
|PE ratio (TTM)||38.89|
|Forward dividend & yield||1.76 (0.82%)|
|Ex-dividend date||08 Feb 2023|
|1y target est||N/A|
U.S. stock markets are going through an unusually volatile period, thanks to the uncertainty posed by the global banking crisis and the Federal Reserve's plan for interest rates. While wild price swings can be nerve-racking for shareholders, choppy markets can also be a great time to pick up shares of top companies at significant discounts to their intrinsic value. Which growth stocks are on watch for a possible entry point?
Investors are optimistic about ResMed's (RMD) Increased demand for its digital health solution.
EYE vs. RMD: Which Stock Is the Better Value Option?